NM_021098.3:c.1120-8C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.1120-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0117 in 1,565,138 control chromosomes in the GnomAD database, including 139 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0091 ( 12 hom., cov: 32)
Exomes 𝑓: 0.012 ( 127 hom. )

Consequence

CACNA1H
NM_021098.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00007083
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.01

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-1200708-C-T is Benign according to our data. Variant chr16-1200708-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 460040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00913 (1387/151962) while in subpopulation NFE AF = 0.0147 (997/68022). AF 95% confidence interval is 0.0139. There are 12 homozygotes in GnomAd4. There are 638 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1387 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 33 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 33 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 33 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.1081-8C>T splice_region_variant, intron_variant Intron 7 of 34 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 33 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.1081-8C>T splice_region_variant, intron_variant Intron 7 of 33 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 35 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 35 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1120-8C>T splice_region_variant, intron_variant Intron 7 of 33 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 36 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 33 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*567-8C>T splice_region_variant, intron_variant Intron 6 of 33 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 35 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 35 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 35 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 35 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 36 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 35 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1120-8C>T splice_region_variant, intron_variant Intron 7 of 34 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.00914
AC:
1388
AN:
151844
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00232
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0132
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00539
Gnomad FIN
AF:
0.00292
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0147
Gnomad OTH
AF:
0.0101
GnomAD2 exomes
AF:
0.00873
AC:
1522
AN:
174388
AF XY:
0.00918
show subpopulations
Gnomad AFR exome
AF:
0.00268
Gnomad AMR exome
AF:
0.00749
Gnomad ASJ exome
AF:
0.00183
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00427
Gnomad NFE exome
AF:
0.0137
Gnomad OTH exome
AF:
0.0107
GnomAD4 exome
AF:
0.0120
AC:
16976
AN:
1413176
Hom.:
127
Cov.:
33
AF XY:
0.0120
AC XY:
8380
AN XY:
698874
show subpopulations
African (AFR)
AF:
0.00178
AC:
57
AN:
32062
American (AMR)
AF:
0.00716
AC:
267
AN:
37274
Ashkenazi Jewish (ASJ)
AF:
0.00205
AC:
52
AN:
25338
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36648
South Asian (SAS)
AF:
0.00737
AC:
599
AN:
81276
European-Finnish (FIN)
AF:
0.00407
AC:
201
AN:
49332
Middle Eastern (MID)
AF:
0.0109
AC:
60
AN:
5524
European-Non Finnish (NFE)
AF:
0.0139
AC:
15149
AN:
1087104
Other (OTH)
AF:
0.0101
AC:
591
AN:
58618
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
795
1590
2384
3179
3974
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00913
AC:
1387
AN:
151962
Hom.:
12
Cov.:
32
AF XY:
0.00859
AC XY:
638
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.00231
AC:
96
AN:
41554
American (AMR)
AF:
0.0132
AC:
197
AN:
14978
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.00539
AC:
26
AN:
4824
European-Finnish (FIN)
AF:
0.00292
AC:
31
AN:
10622
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0147
AC:
997
AN:
68022
Other (OTH)
AF:
0.00995
AC:
21
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
73
146
218
291
364
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0124
Hom.:
17
Bravo
AF:
0.00879
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H: BP4, BS1, BS2 -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 20, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 04, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 04, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CACNA1H-related disorder Benign:1
Apr 26, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
2.7
DANN
Benign
0.32
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000071
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59091981; hg19: chr16-1250708; API